| Nov 27 2023 |
Unpacking Packaging, Labeling, Preparation, and Destruction of Cannabis Products under SB 846 |
Norris McLaughlin P.A. |
| Nov 27 2023 |
O-high-o: Ohio Voters vote to Legalize Recreational Cannabis |
Norris McLaughlin P.A. |
| Nov 27 2023 |
Back Pain, Legal Strains, and CBD Gains: Pennsylvania Court’s High Stakes Ruling on CBD Compensation |
Norris McLaughlin P.A. |
| Nov 27 2023 |
FDA Releases Infant Formula Risk Management Plan Fact Sheet |
Keller and Heckman LLP |
| Nov 23 2023 |
EC Asks SCCS to Assess Safety of Hydroxyapatite (Nano) in View of New Information |
Bergeson & Campbell, P.C. |
| Nov 22 2023 |
Global Regulatory Update for November 2023 |
Bergeson & Campbell, P.C. |
| Nov 22 2023 |
FDA Delays Enforcement of MOCRA Deadlines for Facility Registration and Product Listing to July 1, 2024 |
Squire Patton Boggs (US) LLP |
| Nov 22 2023 |
Elevated Lead Levels Found in Children’s Fruit Pouches: Anatomy of a Recall |
Womble Bond Dickinson (US) LLP |
| Nov 22 2023 |
FDA Published Updated Leafy Green STEC Action Plan |
Keller and Heckman LLP |
| Nov 22 2023 |
Canadian Court Invalidates Plastics ‘Toxic’ Designation |
Keller and Heckman LLP |
| Nov 22 2023 |
FTC Warns Influencers and Trade Associations to Be Much More Specific About Ties |
Hunton Andrews Kurth |
| Nov 21 2023 |
Petition Requests that FDA Amend Flavoring Regulation |
Keller and Heckman LLP |
| Nov 21 2023 |
Voluntary Self-Disclosure of FCPA Violations Following Acquisition Avoids Corruption Charges |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 20 2023 |
FDA Announces Updates to Dietary Supplement Program |
Greenberg Traurig, LLP |
| Nov 20 2023 |
Sharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don’ts Under FDA’s New Draft Guidance |
Epstein Becker & Green, P.C. |
| Nov 20 2023 |
The LDT Debate: Unpacking Public Responses to FDA’s Proposed Rule |
Mintz |
| Nov 20 2023 |
Big Brother Cancels Trip, Court Says Not So Fast My Friend |
Bradley Arant Boult Cummings LLP |
| Nov 20 2023 |
Imported Cantaloupe Recalled in U.S. and Canada |
Keller and Heckman LLP |
| Nov 17 2023 |
HHS Issues Provider Information Blocking Disincentives Proposed Rule |
McDermott Will & Schulte LLP |
| Nov 17 2023 |
Indecent Disclosure: FTC Slams Advertisers and Influencers for Failure to Divulge Material Connections |
Mintz |
| Nov 17 2023 |
Revisiting FDA’s Original Guidance on Orange Book Listability in Light of Heightened FTC Scrutiny |
Foley & Lardner LLP |
| Nov 17 2023 |
OIG Issues General Compliance Program Guidance Updates |
McDermott Will & Schulte LLP |
| Nov 17 2023 |
O-H-High-O: Ohio Adopts Adult-Use Marijuana Program |
Bradley Arant Boult Cummings LLP |
| Nov 17 2023 |
Sustainability Update: NGO and International Efforts to Regulate Plastic |
ArentFox Schiff LLP |
| Nov 16 2023 |
MoCRA Enforcement Pushed Six Months |
Beveridge & Diamond PC |
| Nov 16 2023 |
Fighting for Access to Lifesaving HIV Medicine |
Mintz |
| Nov 16 2023 |
FDA Delays Enforcement of Cosmetic Product Facility Registration and Listing Requirements |
Greenberg Traurig, LLP |
| Nov 16 2023 |
APHIS Proposes Five Additional Exemptions for Plants Modified or Produced Through Genetic Engineering |
Bergeson & Campbell, P.C. |
| Nov 16 2023 |
Resorting to Extrinsic Evidence Is Necessary When Intrinsic Evidence Is Muddied |
McDermott Will & Schulte LLP |
| Nov 16 2023 |
FTC Warns Two Trade Associations and 12 Online Influencers to Better Disclose Financial Connections |
Keller and Heckman LLP |
| Nov 16 2023 |
October 2023 Bounty Hunter Plaintiff Claims |
Keller and Heckman LLP |
| Nov 16 2023 |
Recent Federal Developments - November, 2023 |
Bergeson & Campbell, P.C. |
| Nov 15 2023 |
Florida Proposes New Pharmacy Benefit Manager Rules |
Polsinelli PC |
| Nov 15 2023 |
Third Time’s A Charm: California Re-Introduces Proposed Changes to Proposition 65’s Warnings and Safe Harbor Requirements |
ArentFox Schiff LLP |
| Nov 15 2023 |
This Week in 340B: November 6 – 12, 2023 |
McDermott Will & Schulte LLP |
